Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018581
Filing Date
2016-05-09
Accepted
2016-05-09 16:09:04
Documents
59
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tbra-10q_20160331.htm 10-Q 1212122
2 EX-10.1 tbra-ex101_549.htm EX-10.1 641100
3 EX-10.2 tbra-ex102_550.htm EX-10.2 635979
4 EX-31.1 tbra-ex311_6.htm EX-31.1 16968
5 EX-31.2 tbra-ex312_8.htm EX-31.2 18272
6 EX-32.1 tbra-ex321_7.htm EX-32.1 8580
7 EX-32.2 tbra-ex322_9.htm EX-32.2 9080
  Complete submission text file 0001564590-16-018581.txt   5400760

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT tbra-20160331.xml EX-101.INS 818766
9 XBRL TAXONOMY EXTENSION SCHEMA tbra-20160331.xsd EX-101.SCH 36936
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tbra-20160331_cal.xml EX-101.CAL 34703
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tbra-20160331_def.xml EX-101.DEF 79171
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbra-20160331_lab.xml EX-101.LAB 248847
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbra-20160331_pre.xml EX-101.PRE 184357
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Filer) CIK: 0001311596 (see all company filings)

EIN.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35953 | Film No.: 161631716
SIC: 2834 Pharmaceutical Preparations